Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marjon H Cnossen

Showing results (1-10 of 155) with videos related to

Pageof 16
Sort By:
Drugs|August 10, 2017
Current and Emerging Options for the Management of Inherited von Willebrand DiseaseJessica M Heijdra, Marjon H Cnossen, Frank W G Leebeek
Clinical Pharmacology and Therapeutics|May 19, 2025
Relationship between Dose, Factor IX Activity Levels and Bleeding Probability for rIX-FP Prophylaxis in Hemophilia B: A Repeated Time-to-Event AnalysisSjoerd F Koopman, Marjon H Cnossen, Ron A A Mathot, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 25, 2025
In Silico Assessment of Limited Blood Sampling Strategies for Individualised Pharmacokinetic-guided Dosing of Efanesoctocog Alfa in Haemophilia A PatientsJelien den Hollander, Marjon H Cnossen, Ron A A Mathôt
CPT: Pharmacometrics & Systems Pharmacology|December 15, 2023
Application of SHAP values for inferring the optimal functional form of covariates in pharmacokinetic modelingAlexander Janssen, Mark Hoogendoorn, Marjon H Cnossen, et al.
BMJ (Clinical Research Ed.)|May 4, 2012
Diagnosis and management of haemophiliaKarin Fijnvandraat, Marjon H Cnossen, Frank W G Leebeek, et al.
BMJ Case Reports|April 13, 2021
Impact of extreme weight loss on factor VIII concentrate pharmacokinetics in haemophiliaIris van Moort, Laura H Bukkems, Laurens Nieuwenhuizen, et al.
Journal of Thrombosis and Haemostasis : JTH|May 30, 2025
A repeated time-to-event model for personalized treatment of patients with hemophilia A based on individual bleeding riskAlexander Janssen, Frank C Bennis, Marjon H Cnossen, et al.
BMJ Case Reports|January 16, 2019
Pharmacokinetic-guided dosing of factor VIII concentrate in a morbidly obese severe haemophilia A patient undergoing orthopaedic surgeryTim Preijers, Britta Ap Laros-vanGorkom, Ron Aa Mathôt, et al.
Journal of Pharmacokinetics and Pharmacodynamics|March 27, 2024
On inductive biases for the robust and interpretable prediction of drug concentrations using deep compartment modelsAlexander Janssen, Frank C Bennis, Marjon H Cnossen, et al.
Journal of Pharmacokinetics and Pharmacodynamics|July 4, 2024
Mixed effect estimation in deep compartment models: Variational methods outperform first-order approximationsAlexander Janssen, Frank C Bennis, Marjon H Cnossen, et al.
Pageof 16

Showing results (1-10 of 155) with videos related to

Sort By:
Pageof 16
Drugs|August 10, 2017
Current and Emerging Options for the Management of Inherited von Willebrand DiseaseJessica M Heijdra, Marjon H Cnossen, Frank W G Leebeek
Clinical Pharmacology and Therapeutics|May 19, 2025
Relationship between Dose, Factor IX Activity Levels and Bleeding Probability for rIX-FP Prophylaxis in Hemophilia B: A Repeated Time-to-Event AnalysisSjoerd F Koopman, Marjon H Cnossen, Ron A A Mathot, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 25, 2025
In Silico Assessment of Limited Blood Sampling Strategies for Individualised Pharmacokinetic-guided Dosing of Efanesoctocog Alfa in Haemophilia A PatientsJelien den Hollander, Marjon H Cnossen, Ron A A Mathôt
CPT: Pharmacometrics & Systems Pharmacology|December 15, 2023
Application of SHAP values for inferring the optimal functional form of covariates in pharmacokinetic modelingAlexander Janssen, Mark Hoogendoorn, Marjon H Cnossen, et al.
BMJ (Clinical Research Ed.)|May 4, 2012
Diagnosis and management of haemophiliaKarin Fijnvandraat, Marjon H Cnossen, Frank W G Leebeek, et al.
BMJ Case Reports|April 13, 2021
Impact of extreme weight loss on factor VIII concentrate pharmacokinetics in haemophiliaIris van Moort, Laura H Bukkems, Laurens Nieuwenhuizen, et al.
Journal of Thrombosis and Haemostasis : JTH|May 30, 2025
A repeated time-to-event model for personalized treatment of patients with hemophilia A based on individual bleeding riskAlexander Janssen, Frank C Bennis, Marjon H Cnossen, et al.
BMJ Case Reports|January 16, 2019
Pharmacokinetic-guided dosing of factor VIII concentrate in a morbidly obese severe haemophilia A patient undergoing orthopaedic surgeryTim Preijers, Britta Ap Laros-vanGorkom, Ron Aa Mathôt, et al.
Journal of Pharmacokinetics and Pharmacodynamics|March 27, 2024
On inductive biases for the robust and interpretable prediction of drug concentrations using deep compartment modelsAlexander Janssen, Frank C Bennis, Marjon H Cnossen, et al.
Journal of Pharmacokinetics and Pharmacodynamics|July 4, 2024
Mixed effect estimation in deep compartment models: Variational methods outperform first-order approximationsAlexander Janssen, Frank C Bennis, Marjon H Cnossen, et al.
Pageof 16